Association of serum neurofilament light with microglial activation in multiple sclerosis
Open Access
- 2 May 2023
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 94 (9) , 698-706
Abstract
Background: Translocator protein (TSPO)-PET and neurofilament light (NfL) both report on brain pathology, but their potential association has not yet been studied in multiple sclerosis (MS) in vivo. We aimed to evaluate the association between serum NfL (sNfL) and TSPO-PET-measurable microglial activation in the brain of patients with MS.Methods: Microglial activation was detected using PET and the TSPO-binding radioligand [11C]PK11195. Distribution volume ratio (DVR) was used to evaluate specific [11C]PK11195-binding. sNfL levels were measured using single molecule array (Simoa). The associations between [11C]PK11195 DVR and sNfL were evaluated using correlation analyses and false discovery rate (FDR) corrected linear regression modelling.Results: 44 patients with MS (40 relapsing-remitting and 4 secondary progressive) and 24 age-matched and sex-matched healthy controls were included. In the patient group with elevated brain [11C]PK11195 DVR (n=19), increased sNfL associated with higher DVR in the lesion rim (estimate (95% CI) 0.49 (0.15 to 0.83), p(FDR)=0.04) and perilesional normal appearing white matter (0.48 (0.14 to 0.83), p(FDR)=0.04), and with a higher number and larger volume of TSPO-PET-detectable rim-active lesions defined by microglial activation at the plaque edge (0.46 (0.10 to 0.81), p(FDR)=0.04 and 0.50 (0.17 to 0.84), p(FDR)=0.04, respectively). Based on the multivariate stepwise linear regression model, the volume of rim-active lesions was the most relevant factor affecting sNfL.Conclusions: Our demonstration of an association between microglial activation as measured by increased TSPO-PET signal, and elevated sNfL emphasises the significance of smouldering inflammation for progression-promoting pathology in MS and highlights the role of rim-active lesions in promoting neuroaxonal damage.Keywords
Funding Information
- InFLAMES Flagship Programme of the Academy of Finland (337530)
- Finnish MS Foundation (N/A)
- Suomen Lääketieteen Säätiö (N/A)
- Research Council of Finland (330902)
- Sigrid Juselius Foundation (N/A)
This publication has 39 references indexed in Scilit:
- Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis LesionsFrontiers in Immunology, 2018
- Minocycline reduces chronic microglial activation after brain trauma but increases neurodegenerationBrain, 2017
- Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosisBrain, 2017
- Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisAnnals of Neurology, 2017
- In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195Journal of Nuclear Medicine, 2014
- Optimization of Supervised Cluster Analysis for Extracting Reference Tissue Input Curves in (R)-[11C]PK11195 Brain PET StudiesJournal of Cerebral Blood Flow & Metabolism, 2012
- Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlationsAnnals of Neurology, 2011
- Activated Microglia Mediate Axoglial Disruption That Contributes to Axonal Injury in Multiple SclerosisJournal of Neuropathology & Experimental Neurology, 2010
- The relation between inflammation and neurodegeneration in multiple sclerosis brainsBrain, 2009
- Reference and target region modeling of [11C]-(R)-PK11195 brain studies.2007